Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that oral administration of specific Lactobacillus strains induced the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut-similar to the effects of morphine. These results suggest that the microbiology of the intestinal tract influences our visceral perception, and suggest new approaches for the treatment of abdominal pain and irritable bowel syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A few putative mechanisms include: microbial induction of epithelial μ-opioid and cannabinoid receptors as shown with oral administration of Lactobacillus strains in rodents69”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [69]
In the citing paper
“The use of probiotics, particularly in animal models, also demonstrates that their secreted products or metabolites can modulate contractility of intestinal smooth muscle and visceral sensitivity.59–61”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [60]
In the citing paper
“Interestingly, we saw beneficial effects especially on distension and pain, as this agrees well with the recent findings that certain lactobacilli can induce the expression of pain-sensing receptors in intestinal epithelial cells. 33”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [33]
In the citing paper
“In addition, exposure of rats to L. reuteri (83) or L. acidophilus NCFM (151) reduce their pain response to balloon distension, through targeting ion channels in the enteric nervous system (83, 91) or increasing the expression of μ-opioid and cannabinoid receptors in intestinal epithelial cells (151).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [151]
In the citing paper
“Evidence for such mutual interaction has been demonstrated in gut inflammation,14 visceral pain,77 certain symptoms of IBS,12 and in obesity.78”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [77]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gut flora in health and disease
Guarner, F., & Malagelada, J.-R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,365
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Falk, P. G., Hooper, L. V., Midtvedt, T., & Gordon, J. I. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1157-1170.1998 · Cited by 657
Attacking pain at its source: new perspectives on opioids
Stein, C., Schäfer, M., & Machelska, H. (2003) · Nature Medicine · doi:10.1038/nm908 · Cited by 608
Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM
Altermann, E., Russell, W. M., Azcarate-Peril, M. A., Barrangou, R., Buck, B. L., McAuliffe, O., Souther, N., Dobson, A., Duong, T., Callanan, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409188102 · Cited by 590
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
Cervero, F., & Laird, J. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01306-9 · Cited by 434
Invited Review: The Scientific Basis of Lactobacillus acidophilus NCFM Functionality as a Probiotic
Sanders, M. E., & Klaenhammer, T. R. (2001) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(01)74481-5 · Cited by 433
KAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361
WRIGHT, K., ROONEY, N., FEENEY, M., TATE, J., ROBERTSON, D., WELHAM, M., & WARD, S. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.026 · Cited by 299
Cited by
Items 201–300 of 793
Man and the Microbiome: A New Theory of Everything?
Butler, M., Cryan, J. F., & Dinan, T. G. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095432 · Cited by 103
Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 98
Stress and visceral pain: Focusing on irritable bowel syndrome
Fukudo, S. (2013) · Pain · doi:10.1016/j.pain.2013.09.008 · Cited by 90
“First, although research on molecular mechanisms [6,16,34,53,66,67,80] and microbiome mechanisms [63,70,81] is advancing rapidly, most studies have been conducted in rodents.”
BackgroundHord, N. G. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155402 · Cited by 91
Brusberg, M., Arvidsson, S., Kang, D., Larsson, H., Lindström, E., & Martinez, V. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5166-08.2009 · Cited by 88
“Recent studies in several species, including humans, support a role for endocannabinoids modulating visceral pain (Jaggar et al., 1998; Farquhar-Smith et al., 2002; Sanson et al., 2006; Esfandyari et al., 2007; Rousseaux et al., 2007; Kikuchi et al., 2008).”
Backgroundde Azúa, I. R., & Lutz, B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2994-6 · Cited by 94
AKBAR, A., WALTERS, J. R. F., & GHOSH, S. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04056.x · Cited by 88
Gut microbiota and the role of probiotics in therapy
Quigley, E. M. M. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.010 · Cited by 102
The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome
Gu, Y., Zhou, G., Qin, X., Huang, S., Wang, B., & Cao, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01894 · Cited by 88
The enteric microbiota in the pathogenesis and management of constipation
Quigley, E. M. M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.01.003 · Cited by 93
“Of relevance to constipation, probiotics may also produce other chemicals, including neurotransmitters, that can modify other gut functions, such as motility [38,39] or sensation [40,41].”
BackgroundStorr, M. A., Yüce, B., Andrews, C. N., & Sharkey, K. A. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01175.x · Cited by 86
Talley, N. J. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01217.x · Cited by 87
Lactobacillus acidophilus CRL 1014 improved “gut health” in the SHIME®reactor
Sivieri, K., Morales, M. L. V., Adorno, M. Â. T., Sakamoto, I. K., Saad, S. M. I., & Rossi, E. A. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-100 · Cited by 103
“Gut microbiota is composed of different bacterial species, which are involved in the metabolism of nutrients, the maturation of the intestinal epithelium, vasculature and lymphoid tissue, and protection against pathogens [2].”
BackgroundNon-dairy Based Probiotics: A Healthy Treat for Intestine
Bansal, S., Mangal, M., Sharma, S. K., & GUPTA, R. K. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.790780 · Cited by 85
“, 2007), and producing substances that affect intestinal pain receptors (Rousseaux et al., 2007; Zocco et al., 2007).”
BackgroundBested, A. C., Logan, A. C., & Selhub, E. M. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-4 · Cited by 84
“These findings take on greater meaning given the preliminary findings regarding the ability of probiotic strains to enhance CB-2 expression [86].”
Probiotics and irritable bowel syndrome
Dai, C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i36.5973 · Cited by 85
Dong, T. S., & Mayer, E. A. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.024 · Cited by 92
Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome
Theodorou, V., Ait-Belgnaoui, A., Agostini, S., & Eutamene, H. (2014) · Gut Microbes · doi:10.4161/gmic.29796 · Cited by 83
“Alterations in the gut microbiota and inflammatory tone induced by non absorbable antibiotics treatment enhanced visceral sensitivity and substance P expression in the colonic mucosa.55 These effects were prevented by L paracasei administration.55 In another study, treatment with live, killed, or even the conditioned…”
BackgroundInfluentialHow do probiotics and prebiotics function at distant sites?
Reid, G., Abrahamsson, T., Bailey, M. T., Bindels, L. B., Bubnov, R. V., Ganguli, K. A., Martoni, C., O’Neill, C. A., Savignac, H. M., Stanton, C., et al. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0222 · Cited by 90
Endocannabinoids in the gastrointestinal tract
Lee, Y., Jo, J., Chung, H. Y., Pothoulakis, C., & Im, E. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00294.2015 · Cited by 97
“(109), who showed that CB2 receptor expression was increased by treating intestinal epithelial cells with a Lactobacillus acidophilus strain, and that oral administration of this strain reduced abdominal pain in rats.”
BackgroundCurrent evidence linking diet to gut microbiota and brain development and function
Ceppa, F., Mancini, A., & Tuohy, K. M. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1462309 · Cited by 92
“Similarly, the expression of m-opioid and cannabinoid receptors in intestinal epithelial cells could be induced by Lactobacillus strains, which mimic the effects of morphine in promoting analgesia (Rousseaux et al. 2007).”
BackgroundCitraro, R., Lembo, F., Caro, C. D., Tallarico, M., Coretti, L., Iannone, L. F., Leo, A., Palumbo, D., Cuomo, M., Buommino, E., et al. (2021) · Epilepsia · doi:10.1111/epi.16813 · Cited by 90
Systematic review of evidence to support the theory of psychobiotics
Romijn, A. R., & Rucklidge, J. J. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv025 · Cited by 81
Probiotics in Extraintestinal Diseases: Current Trends and New Directions
Kiousi, D. E., Karapetsas, A., Karolidou, K., Panayiotidis, M. I., Pappa, A., & Galanis, A. (2019) · Nutrients · doi:10.3390/nu11040788 · Cited by 66
“Conclusively, rats receiving probiotic supplementation exhibited increased pain thresholds during colorectal distention [98].”
BackgroundRole of the endocannabinoid system in the regulation of intestinal homeostasis
Cuddihey, H., MacNaughton, W. K., & Sharkey, K. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.015 · Cited by 79
Use of probiotics in the fight againstHelicobacter pylori
Ruggiero, P. (2014) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v5.i4.384 · Cited by 79
Wu, L., Zhou, J., Zhou, A., Lei, Y., Tang, L., Hu, S., Wang, S., Xu, X., Chen, Q., Tu, D., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2390176 · Cited by 96
“34 In another study, administration of L. acidophilus provided pain relief 35 and prevented antibiotic-associated diarrhea.”
ResultUsing Probiotics in Gastrointestinal Disorders
Ringel, Y., Quigley, E. M., & Lin, H. C. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.7 · Cited by 77
Ringel‐Kulka, T., Goldsmith, J. R., Carroll, I. M., Barros, S. P., Palsson, O., Jobin, C., & Ringel, Y. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12800 · Cited by 72
The endocannabinoid system in cancer—Potential therapeutic target?
Flygare, J., & Sander, B. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.12.008 · Cited by 77
“[108] Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, et al.”
BackgroundEffect of probiotics on symptoms in Korean adults with irritable bowel syndrome
Hong, K. S., Kang, H. W., Im, J. P., Ji, G. E., Kim, S. G., Jung, H. C., Song, I. S., & Kim, J. S. (2009) · Gut and Liver · doi:10.5009/gnl.2009.3.2.101 · Cited by 75
“Regarding the reduction of abdominal pain by probiotics, a recent study demonstrated that one strain of Lactobacillus acidophilus induced the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells of rodents and mediated analgesic functions in the gut.(21) As described in introduction, consid…”
ResultImpact of genomics on the field of probiotic research: historical perspectives to modern paradigms
Johnson, B. R., & Klaenhammer, T. R. (2014) · Antonie van Leeuwenhoek · doi:10.1007/s10482-014-0171-y · Cited by 72
“…al. (2004), Gao et al. (2010) Reduction in intestinal bloating Ringel-Kulka et al. (2011) Abdominal pain analgesic (via l-opiod and cannabinoid receptors) Rousseaux et al. (2007) Lowered levels of cold and influenza-like symptoms in children Leyer et al. (2009) Antimicrobial activity Ryan et al.…”
BackgroundUnraveling the ties between irritable bowel syndrome and intestinal microbiota
Hong, S. N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2470 · Cited by 75
Oxidized Lipids in Persistent Pain States
Osthues, T., & Sisignano, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01147 · Cited by 81
The Comparition of the Efficacy of Two Different Probiotics in Rotavirus Gastroenteritis in Children
Erdoğan, Ö., Tanyeri, B., Torun, E., Gönüllü, E., Arslan, H., Erenberk, U., & Öktem, F. (2012) · Journal of Tropical Medicine · doi:10.1155/2012/787240 · Cited by 74
“Probiotics are commonly used in viral diarrhea in order to suppress the growth or epithelial invasion of pathogenic bacteria in the human gut, improve the intestinal barrier function, modulate the immune system of the intestine, and mediate analgesic functions [14, 15].”
BackgroundLactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study
Jadrešin, O., Hojsak, I., Mišak, Z., Kekez, A. J., Trbojević, T., Ivković, L., & Kolaček, S. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001478 · Cited by 71
Matisz, C. E., & Gruber, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.020 · Cited by 74
Dairy probiotics: Beyond the role of promoting gut and immune health
Ζουμποπούλου, Γ., Pot, B., Tsakalidou, E., & Papadimitriou, K. (2016) · International Dairy Journal · doi:10.1016/j.idairyj.2016.09.010 · Cited by 83
The immunomodulatory role of probiotics in allergy therapy
Hajavi, J., Esmaeili, S., Varasteh, A., Vazini, H., Atabati, H., Mardani, F., Momtazi‐Borojeni, A. A., Hashemi, M., Sankian, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27263 · Cited by 73
“addition to Treg cell generation and tolerance acquisition (Rousseaux et al., 2007; Yan et al., 2007).”
BackgroundYu, M., Zhang, R., Ni, P., Chen, S., & Duan, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223309 · Cited by 77
“also activate opioid and cannabinoid receptors, thus alleviating the discomfort caused by antibiotics and possibly reducing side effects [43].”
BackgroundShen, C., Wang, R., Ji, G., Elmassry, M. M., Zabet‐Moghaddam, M., Vellers, H. L., Hamood, A. N., Gong, X., Mirzaei, P., Sang, S., et al. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108904 · Cited by 71
Klooker, T. K., Leliefeld, K. E. M., Van Den Wijngaard, R. M., & Boeckxstaens, G. E. E. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01587.x · Cited by 53
Kannampalli, P., Pochiraju, S., Chichlowski, M., Berg, B. M., Rudolph, C., Bruckert, M., Miranda, A., & Sengupta, J. N. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12450 · Cited by 74
Annalisa, N., Alessio, T., Claudette, T. D., Erald, V., Antonino, D. L., & Nicola, D. D. (2014) · Mediators of Inflammation · doi:10.1155/2014/901308 · Cited by 68
“[62] as well as those acting as vitamins [63] or energy sources [64].”
Endocannabinoids and the gastrointestinal tract: what are the key questions?
Sanger, G. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707422 · Cited by 68
“Similar activity was also observed using 2-AG but this was prevented by the selective CB1 receptor antagonist AM251 and also by the CB2 receptor antagonist 6-iodo-r-methyl-1[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone (AM630); a possible involvement of the CB2 receptor in the activity of 2-AG is c…”
BackgroundInfluentialNiccolai, E., Boem, F., Russo, E., & Amedei, A. (2019) · Nutrients · doi:10.3390/nu11010156 · Cited by 77
“acidophilus NCFM increased gut expression of opioid and cannabinoid receptors in epithelial cell culture [207].”
BackgroundQuigley, E. M. M. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.009 · Cited by 67
Quigley, E. M. M. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.07.012 · Cited by 67
Markers for visceral hypersensitivity in patients with irritable bowel syndrome
Ludidi, S., Mujagic, Z., Jonkers, D. M. A. E., Keszthelyi, D., Hesselink, M., Kruimel, J. W., Conchillo, J. M., & Masclee, A. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12365 · Cited by 74
Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota
Wisniewski, P. J., Dowden, R. A., & Campbell, S. C. (2019) · Nutrients · doi:10.3390/nu11010117 · Cited by 71
“Interestingly, some strains of microbes may minimize visceral sensitivity by upregulating CB2 expression in the intestinal epithelium of rats [184], but conversely in humans there was a reduction in CB2 expression [185].”
BackgroundVisceral Pain and Gastrointestinal Microbiome
Chichlowski, M., & Rudolph, C. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15025 · Cited by 63
“Animal models have been useful to demonstrate potential mechanisms by which the microbiome can modulate visceral pain responses.(2,3,40-43) In GF mice, contact with commensal microbiota is necessary for mice to develop pain sensitivity, possibly in a toll-like receptor (TLR)-dependent manner.”
Opioid system influences gut-brain axis: Dysbiosis and related alterations
Rueda‐Ruzafa, L., Cruz, F., Cardona, D., Hone, A. J., Molina‐Torres, G., Sánchez‐Labraca, N., & Román, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104928 · Cited by 69
Dutra, R. C., da Silva, K. A. B. S., Bento, A. F., Marcon, R., Paszcuk, A. F., Meotti, F. C., Pianowski, L. F., & Calixto, J. Β. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.008 · Cited by 68
Microbiome to Brain: Unravelling the Multidirectional Axes of Communication
Aidy, S. E., Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20215-0_15 · Cited by 69
“…normal gut microbiome, signifi cant changes in adult depression like behaviour (Schroeder et al. 2007 ), nociceptive responses (Amaral et al. 2008 ; Rousseaux et al. 2007 ), stress responsiveness (Gareau et al. 2007 ) and social development (Desbonnet et al. 2014 ) have been shown, and these…”
BackgroundWojtyniak, K., Horvath, A., Dziechciarz, P., & Szajewska, H. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.01.068 · Cited by 69
Endocannabinoid system modulation in cancer biology and therapy
Pisanti, S., & Bifulco, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.011 · Cited by 67
Ait‐belgnaoui, A., Eutamene, H., Houdeau, E., Bueno, L., Fioramonti, J., & Theodorou, V. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01280.x · Cited by 61
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain
Cuozzo, M., Castelli, V., Avagliano, C., Cimini, A., d’Angelo, M., Cristiano, C., & Russo, R. (2021) · Biomedicines · doi:10.3390/biomedicines9040346 · Cited by 67
“In 2007, Rousseaux showed the correlation between microbiota and endocannabinoids and opioids receptors, suggesting that intestinal flora’s modulation may be a promising, safe and relatively low-cost novel treatment for abdominal pain [18].”
BackgroundProbiotics in functional gastrointestinal disorders: what are the facts?
Quigley, E. M. M. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.007 · Cited by 70
“Acidophilus has been shown to induce the expression of m-opioid and cannabinoid receptors in human intestinal epithelial cells [31].”
BackgroundShi, Y., Zhao, X., Zhao, J., Zhang, H., Zhai, Q., Narbad, A., & Chen, W. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.13687 · Cited by 68
“2017), and there is evidence that Lactobacillus strains isolated from fermented foods can provide health benefits (Rousseaux et al. 2007).”
BackgroundThe microbiome and disorders of the central nervous system
Felice, V. D., & O'Mahony, S. M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.016 · Cited by 60
“Moreover, treatment with Lactobacillus acidophilus has been shown to mediate an analgesic effect in the gut by potentially inducing the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells (Rousseaux et al., 2007).”
O’Flaherty, S., & Klaenhammer, T. R. (2010) · Microbiology · doi:10.1099/mic.0.043158-0 · Cited by 64
“acidophilus have demonstrated modulation of intestinal pain and induction of pain receptors in intestinal cells which exert analgesic effects in colitis models (Rousseaux et al., 2007), and activation of toll-like receptors and dendritic cells (Konstantinov et al.”
BackgroundProtease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria
Sessenwein, J. L., Baker, C. C., Pradhananga, S., Maitland, M. E., Petrof, E. O., Allen-Vercoe, E., Noordhof, C., Reed, D. E., Vanner, S. J., & Lomax, A. E. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1672-17.2017 · Cited by 58
“…with visceral pain (Soderholm et al., 2001; Sánchez de Medina et al., 2014), and a contribution of the microbiota to pain generation in these conditions has been suggested (Kamiya et al., 2006; Rousseaux et al., 2007; McKernan et al., 2010; Duncker et al., 2011; Perez-Burgos et al., 2015).”
BackgroundGonzález‐González, F., Delgado, S., Ruíz, L., Margollés, A., & Ruas‐Madiedo, P. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15510 · Cited by 71
“For instance, oral administration of L. acidophilus NCFM and contact of the bacterium with intestinal epithelial cells modulates the perception of visceral pain in rats, by inducing the expression of opioid and cannabinoid receptors in the gut (Rousseaux et al., 2007).”
BackgroundMiquel, S., Beaumont, M., Martín, R., Langella, P., Braesco, V., & Thomas, M. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0229-1 · Cited by 67
“Concerning intake, it is strongly recommended that the final products contain an adequate amount of live bacteria to provide a health benefit [24,25].”
BackgroundEfficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis
Ding, L., Ning, L., & Xu, G. (2019) · Medicine · doi:10.1097/md.0000000000016068 · Cited by 63
“Probiotics, defined as live microorganisms, could change intestinal flora to regulate intestinal function such as to reduce visceral hypersensitivity,([5]) improve the mucosal barrier function, modulate immunity and chronic inflammation,([6,7]) communicate with central nervous system,([8]) influence the gastrointestin…”
BackgroundTreating irritable bowel syndrome with probiotics: the evidence
Parkes, G. C., Sanderson, J. D., & Whelan, K. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s002966511000011x · Cited by 57
“Lactobacillus acidophilus has been shown to up regulate m-opioid and cannaboid receptors in colonic epithelial cell lines and in the colonic epithelium in pretreated rats and mice((38)).”
BackgroundGoh, Y. J., & Klaenhammer, T. R. (2013) · Molecular Microbiology · doi:10.1111/mmi.12338 · Cited by 59
“…intolerance (Kim and Gilliland, 1983), mitigation of cold and influenza-like symptoms in children (Leyer et al., 2009), the modulation of immune cell functions (Konstantinov et al., 2008) and the alleviation of abdominal pain via modulation of the visceral pain perception (Rousseaux et al., 2007).”
BackgroundThe Human Gutome: Nutrigenomics of the Host–Microbiome Interactions
Dimitrov, D. V. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0109 · Cited by 60
“In further studies in animals, oral administration of specific Lactobacillus acidophilus strains has been shown to induce the expression of m -opioid and cannabinoid receptors in intestinal cells and mediate analgesic functions in the gut, similar to the effects of morphine (Rousseaux et al., 2006).”
Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic
Hell, M., Bernhofer, C., Stalzer, P., Kern, J. M., & Claassen, E. (2013) · Beneficial Microbes · doi:10.3920/bm2012.0049 · Cited by 64
“Another direct relation between the nervous system and the gut is the presence, and exquisite sensitivity to probiotics, of opioid and cannabinoid receptors enabling manipulation of visceral perception (including pain; Rousseaux et al., 2007).”
Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
Gyires, K., & Zádori, Z. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160303110150 · Cited by 62
“Increased epithelial expression of CB2 receptors due to oral administration of the Lactobacillus acidophilus NCFM also resulted in reduced visceral perception [159], but it is still not clear, exactly how these epithelial receptors influence the activity of nociceptive pathways.”
Neuropeptides, Microbiota, and Behavior
Holzer, P. D. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.08.005 · Cited by 60
“1), this change going hand in hand with a decrease of the pain reaction to colorectal distension (Rousseaux et al., 2007).”
BackgroundCannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
Kienzl, M., Storr, M., & Schicho, R. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000120 · Cited by 56
“observation for the presence of ECS-microbiota interaction is that Lactobacillus acidophilus induced CB2 receptor expression in intestinal epithelial cells and in the rodent gut mucosa (46).”
BackgroundThe microbiome and gut endocannabinoid system in the regulation of stress responses and metabolism
Srivastava, R. K., Lutz, B., & Ruiz de Azua, I. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.867267 · Cited by 56
Role of the duodenal microbiota in functional dyspepsia
Brown, G., Hoedt, E. C., Keely, S., Shah, A., Walker, M. M., Holtmann, G., & Talley, N. J. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14372 · Cited by 62
Maayah, Z. H., Takahara, S., Ferdaoussi, M., & Dyck, J. R. B. (2020) · Inflammation Research · doi:10.1007/s00011-020-01341-1 · Cited by 63
Dione, N., Lacroix, S., Taschler, U., Deschênes, T., Abolghasemi, A., Leblanc, N., Di Marzo, V., & Silvestri, C. (2020) · Cells · doi:10.3390/cells9122705 · Cited by 52
Probiotics: From Bench to Market
Klein, M., Sanders, M. E., Duong, T., & Young, H. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05839.x · Cited by 54
Probiotics effects on gastrointestinal function: beyond the gut?
Verdu, E. F. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01297.x · Cited by 53
Arebi, N., Gurmany, S., Bullas, D. C., Hobson, A. R., Stagg, A. J., & Kamm, M. A. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03801.x · Cited by 58
Endocannabinoid‐related compounds in gastrointestinal diseases
Pesce, M., D’Alessandro, A., Borrelli, O., Gigli, S., Seguella, L., Cuomo, R., Esposito, G., & Sarnelli, G. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13359 · Cited by 57
Goh, Y. J., & Barrangou, R. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.02669-20 · Cited by 58
Endogenous opiates and behavior: 2007
Bodnar, R. J. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.007 · Cited by 70
“[1078] Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, et al.”
BackgroundDisruption of gut homeostasis by opioids accelerates HIV disease progression
Meng, J., Sindberg, G. M., & Roy, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00643 · Cited by 54
Whole-body systems approaches for gut microbiota-targeted, preventive healthcare
Zhao, L., & Shen, J. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.02.008 · Cited by 53
“Lactobacillus acidophilus can modulate intestinal pain and induce opioid and cannabinoid receptors with the possible production of pain-reliving substances (Rousseaux et al., 2007).”
Jiang, Y., Lu, X., Man, C., Han, L., Shan, Y., Qu, X., Liu, Y., Yang, S.-Q., Xue, Y., & Zhang, Y. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05617-11 · Cited by 50
“acidophilus NCFM with IEC was able to activate the NF- B pathway (32).”
BackgroundMethodInfluentialMicrobiota-based treatments in alcoholic liver disease
Sung, H., Kim, S. W., Hong, M., & Suk, K. T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i29.6673 · Cited by 51
“Finally, probiotic microorganisms may induce the expression of microopiod and cannabinoid receptors, conferring analgesic properties in the context of intestinal pain [69] .”
Ludidi, S., Jonkers, D. M. A. E., Koning, C. J., Kruimel, J. W., Mulder, L. H. C., der Vaart, I. B.-V., Conchillo, J. M., & Masclee, A. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12320 · Cited by 55
Therapeutic Potential of Cannabinoid-Based Drugs
Klein, T., & Newton, C. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_43 · Cited by 57
The intestinal microbiome of infants and the use of probiotics
Indrio, F., & Neu, J. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283444ccb · Cited by 48
Cannabinoid Receptor 1 Gene Polymorphism and Irritable Bowel Syndrome in the Korean Population
Park, J. M., Choi, M., Cho, Y. K., Lee, I. S., Kim, S. W., Choi, K. Y., & Chung, I. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181dd1573 · Cited by 48
“Animal studies showed that endocannabinoid system involved in the antinociceptive pathway.(6,7) Cannabinoid agonist increases colonic compliance and reduces colonic motility in healthy human volunteers.”
BackgroundThe Human Microbiome and Probiotics: Implications for Pediatrics
Hsieh, M. H., & Versalovic, J. A. (2008) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2008.09.001 · Cited by 54
Human intestinal microbiota: Role in development and functioning of the nervous system
Averina, O. V., & Даниленко, В. Н. (2017) · Microbiology · doi:10.1134/s0026261717010040 · Cited by 52
Spinal cord injury and gut microbiota: A review
Jing, Y., Bai, F., & Yu, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118865 · Cited by 50
Anukam, K. C., Hayes, K. C., Summers, K. L., & Reid, G. (2009) · Advances in Urology · doi:10.1155/2009/680363 · Cited by 54
“of lactobacilli can mediate analgesic functions in the gut [11] formed a basis for the present protocol.”
BackgroundLactobacillus paracasei subsp. paracasei B21060 Suppresses Human T-Cell Proliferation
Peluso, I., Fina, D., Caruso, R., Stolfi, C., Caprioli, F., Fantini, M. C., Caspani, G., Grossi, E., Di Iorio, L., Paone, F. M., et al. (2007) · Infection and Immunity · doi:10.1128/iai.01172-06 · Cited by 48
“Moreover, recent data suggest that specific lactobacillus strains might induce the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells (30).”
BackgroundCommunication between the gut microbiota and peripheral nervous system in health and chronic disease
Cook, T. M., & Mansuy‐Aubert, V. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2068365 · Cited by 49
“In animal models, antibiotic treatment causes visceral hypersensitivity,21,144 which can be prevented by probiotic supplementation of Lactobacillus.21,22 Several Lactobacillus and Bifidobacterium23,25 probiotics have been developed and show promise for the treatment of visceral pain in humans, as well.”
BackgroundScientific Validation of Cannabidiol for Management of Dog and Cat Diseases
Alvarenga, I. C., Panickar, K. S., Hess, H., & McGrath, S. (2023) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-081122-070236 · Cited by 60
Fagundes, C. T., Amaral, F. A., Teixeira, A. L., Souza, D. G., & Teixeira, M. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01077.x · Cited by 49
“acidophilus was efficacious in reducing visceral nociceptive perception in rats (58).”
BackgroundSionov, R. V., & Steinberg, D. (2022) · Biomedicines · doi:10.3390/biomedicines10030631 · Cited by 53
Metadata
- Authors
- Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.-F., Ardid, D., & Desreumaux, P.
- Affiliations
- Inserm (FR)
- Université Clermont Auvergne (FR)
- KU Leuven (BE)
- Corresponding author
- Desreumaux, Pierre
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-12-10
- Volume
- 13
- Issue
- 1
- Pages
- 35-37
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1966470298
- Cited by
- 793
- References
- 16
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 38 · 2023: 46 · 2022: 44 · 2021: 48 · 2020: 42 · 2019: 50 · 2018: 53 · 2017: 40 · 2016: 42 · 2015: 34 · 2014: 47 · 2013: 58 · 2012: 44
- FWCI
- 26.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Lactobacillus acidophilus, intestinal pain, abdominal pain, irritable bowel syndrome, visceral hypersensitivity, mu-opioid receptor, cannabinoid receptors, intestinal epithelial cells, gut microbiota, analgesia, probiotics
- MeSH terms
- Administration, Oral, Analgesics, Opioid, Animals, Colon, Dose-Response Relationship, Drug, Humans, Indoles, Intestines, Lactobacillus acidophilus, Male, Mice, Inbred BALB C, Morphine, Naloxone, Narcotic Antagonists, Receptors, Opioid, Rectum, Abdominal Pain, Rats, Sprague-Dawley, Receptors, Opioid, mu, HT29 Cells, Probiotics, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Mice, Rats, Cannabinoid Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.